The agreement with Palatin follows a $1bn deal with Re-Vana earlier this year as Boehringer targets the ophthalmology market.

Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average ...

Novo Nordisk's Wegovy has received accelerated approval for use in patients with metabolic dysfunction-associated ...

Sanofi has received orphan designation from the EMA for rilzabrutinib, a reversible covalent BTK inhibitor, to treat IgG4-RD.

Aquestive has entered a strategic funding agreement worth $75m with RTW Investments, aimed at supporting the potential launch ...

Tonix has received approval from the US FDA for Tonmya (cyclobenzaprine HCl sublingual tablets) to treat fibromyalgia in ...

Clinical supply chains are transforming, and so are the technological barriers to entry for firms in Life Sciences. To stay ...

Precigen’s immunotherapy will likely reduce the need for repeat surgeries in recurrent respiratory papillomatosis (RRP) ...

Clinical trial data management is growing increasingly complex, with inefficiencies driving up costs and delaying timelines.

Amphastar Pharmaceuticals has signed an exclusive licence agreement with Nanjing Anji Biotechnology, focusing on the ...

Ovarian cancer is one of the most challenging malignancies in oncology. Despite advances in diagnosis and treatment, it is ...

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...